Hippocrates Ventures is the world’s first social impact digital therapeutics fund which is completely funded by 100 physician investors investing $100K each for a total fund size of $10 million. Digital therapeutics, also known as software as a drug, is the concept of a digital program having a clinical and repeatable outcome to either prevent or treat disease. Digital therapeutics has the potential to prevent and treat major conditions such as diabetes, heart disease, obesity, smoking cessation, alcoholism, stroke, cancer prevention, stress, mental health conditions, and a variety of other diseases. The global digital therapeutics market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth.
We are a group of physicians and healthcare entrepreneurs that are investing in solutions that will prevent and treat disease and alleviate human suffering using technology. We believe in moonshot thinking just as Startup Health does, which is the concept of having a 25 year-vision to improve healthcare. When JFK said we will go to the moon, he did not know how we will get there. We believe to change healthcare, this same moonshot thinking is required.